Drevogenin A exhibits significant anti-inflammatory and cytotoxic activities, making it a compound of interest in pharmaceutical research. It has been studied for its potential use in cancer therapy due to its ability to induce apoptosis in certain tumor cell lines. Additionally, its anti-inflammatory properties suggest possible application in treating chronic inflammatory diseases. Research is ongoing to evaluate its efficacy and safety profile for therapeutic development.